New generation of salmonella-based, single dose vaccine candidates to fight infant pneumonia

One of the major challenges in modern vaccinology is to engineer vectors that are highly infectious, yet don't cause illness. Trickier still is to ensure that such weapons against infectious disease can be safely disarmed, once their immunogenic work is done. Roy Curtiss, an investigator of vaccines and infectious diseases at Arizona State University's Biodesign Institute, has pursued these goals for 30 years.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news151003976.html">New generation of salmonella-based, single dose vaccine candidates to fight infant pneumonia</a></p> <p>One of the major challenges in modern vaccinology is to engineer vectors that are highly infectious, yet don't cause illness. Trickier still is to ensure that such weapons against infectious disease can be safely disarmed, once their immunogenic work is done. Roy Curtiss, an investigator of vaccines and infectious diseases at Arizona State University's Biodesign Institute, has pursued these goals for 30 years. </p>